Biosimilar adalimumab will become available to the NHS in December 2018.
Please see our Patient ‘Frequently asked questions’ – biosimilar adalimumab which has been written and approved by North Middlesex University Hospital (NMUH), Royal Free Hospital (RFH; including Barnet and Chase Farm), Royal National Orthopaedic Hospital (RNOH), University College London Hospitals (UCLH) and the Whittington Hospital (WH).
Patient groups are supportive of the use of biosimilar adalimumab. Their websites have additional information on biological medicines and biosimilars:
- Crohn’s and Colitis UK
- National Ankylosing Spondylitis Society
- National Rheumatoid Arthritis Society
- Psoriasis Association
Patients are encouraged to call the biosimilar support team on 0203 447 2863 (9am to 5.30pm, Monday to Friday) for any additional information about biosimilar medicines.